IP Library Granted Patent US 8,813,746
Granted Patent B2
US 8,813,746 · App. 12/880,041 · Granted Aug 26, 2014

Nasal continuous positive airway pressure device for lowering patient work-of-breathing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,813,746
App. No.
12/880,041
Granted
Aug 26, 2014
Kind
B2
Abstract

A nasal continuous positive airway pressure device for lowering patient work-of-breathing is described. The device may include an inspiratory tubing in fluid communication with at least two nasal prongs; expiratory tubing; and a generator body coupled there between. The generator body may include at least two jets configured for receiving gas from the inspiratory tubing; and a flow enhancer configured for directing received gas. The flow enhancer may include a gas manager configured for channeling received gas towards a jet impingement point via at least two jet paths; a fluidic flip trigger configured for triggering a fluidic flip of channeled gas back towards the expiratory tubing by directing a first portion of exhaled patient breath towards the jet impingement point along a first pathway; and an isolated pathway manager configured for directing a second portion of the exhaled patient breath along a second pathway towards the expiratory tubing.

Claims (41)

1. A nasal continuous positive airway pressure (nCPAP) device for lowering patient work-of-breathing, said nCPAP device comprising:

inspiratory tubing in fluid communication with at least two nasal prongs;

expiratory tubing; and

a generator body coupled with said inspiratory tubing and said expiratory tubing, said generator body comprising:

at least two jets configured for receiving gas from said inspiratory tubing and directing, via a jet flow, said gas towards said at least two nasal prongs; and

a flow enhancer configured for redirecting said jet flow, said flow enhancer comprising:

a gas manager configured for channeling said jet flow towards a jet impingement point via at least two jet paths;

a fluidic flip trigger configured for triggering a fluidic flip of channeled gas back towards said expiratory tubing by directing a first portion of exhaled patient breath towards said jet impingement point along a first pathway; and

an isolated pathway manager configured for directing a second portion of said exhaled patient breath along a second pathway extending around an outer wall of said flow enhancer within said generator body to said expiratory tubing, said second pathway isolated from said first pathway.

2. The nCPAP of claim 1 , wherein said at least two jets have a jet diameter greater than 0.034 in.

3. The nCPAP of claim 1 , wherein said flow enhancer is spaced a distance apart from an interior surface of said generator body to accommodate said second pathway.

4. The nCPAP of claim 3 , wherein said flow enhancer circles around said interior surface of said generator body.

5. The nCPAP of claim 1 , wherein said flow enhancer is configured to be positioned in parallel with a nare path of a patient.

6. The nCPAP of claim 1 , wherein said at least two jet gas paths are situated angularly with respect to each other.

7. The nCPAP of claim 1 , wherein said inspiratory tubing is coupled with a ventilator.

8. The nCPAP of claim 1 , wherein said at least two nasal prongs are configured to be positioned within nare of a patient.

9. A method for delivering a nasal continuous positive airway pressure to a patient, said method comprising:

during one of a stagnant and inhalation phase, directing jet gas from at least two jets towards a patient's nares along at least two jet paths to meet at a jet impingement point;

triggering a fluidic flip of jet gas flow back through a flow enhancer towards an expiratory limb by directing a first portion of exhaled patient breath towards said jet impingement point; and

directing a second portion of said exhaled patient breath through an isolated path towards said expiratory limb, thereby lowering a patient's work-of-breathing by providing a jet gas entrainment toward said expiratory limb for said first portion of said exhaled patient breath and an unobstructed flow path for said second portion of said exhaled patient breath,

wherein said unobstructed flow path for said second portion extends around an outer wall of said flow enhancer within a generator body to said expiratory limb said unobstructed flow path isolated from said isolated pathway.

10. A flow enhancer disposed within a generator body for use in a nasal continuous positive airway pressure (nCPAP) device for lowering patient work-of-breathing, said flow enhancer comprising:

a gas manager configured for redirecting a jet flow of gas towards a jet impingement point via at least two jet paths;

a fluidic flip trigger configured for triggering a fluidic flip of redirected gas back towards a expiratory limb by directing a first portion of exhaled patient breath towards said jet impingement point along a first pathway; and

an isolated pathway manager configured for directing a second portion of said exhaled patient breath through a second pathway extending around an outer wall of said flow enhancer within said generator body to said expiratory limb, said second pathway isolated from said first pathway.

11. The nCPAP of claim 10 , wherein said flow enhancer is spaced a distance apart from an interior surface of said generator body to accommodate said second pathway.

12. The nCPAP of claim 11 , wherein said flow enhancer circles around said interior surface of said generator body.

13. The nCPAP of claim 10 , wherein said flow enhancer is configured to be positioned in parallel with a nare path of a patient.

14. The nCPAP of claim 10 , wherein said at least two jet gas paths are situated angularly with respect to each other.

15. A nasal continuous positive airway pressure (nCPAP) device for use in an nCPAP system for lowering patient work-of-breathing, said nCPAP device comprising:

at least two inspiratory limbs coupled with a ventilator and in fluid communication with a pair of nasal prongs;

a generator body coupled with said at least two inspiratory limbs and configured for conveying gas received from said at least two inspiratory limbs to said pair of nasal prongs, said generator body comprising:

a flow enhancer configured for redirecting gas moving within said generator body to a pathway of lesser resistance including a first pathway and a second pathway, thereby lowering said patient work-of-breathing;

an expiratory limb coupled with said generator body, said expiratory limb configured for receiving and expelling exhaled patient breath,

wherein said second pathway extends around an outer wall of said flow enhancer within said generator body to said expiratory limb; and an isolated pathway manager configured for directing a second portion of said exhaled patient breath through said second pathway, said second pathway isolated from said first pathway.

16. The nCPAP device of claim 15 , wherein said flow enhancer comprises:

a gas manager configured for channeling gas moving within said generator body towards a jet impingement point via at least two jet paths.

17. The nCPAP device of claim 16 , wherein said flow enhancer further comprises:

a fluidic flip trigger configured for triggering a fluidic flip of channeled gas back towards said expiratory limb by directing a first portion of exhaled patient breath towards said jet impingement point along said first pathway.

18. The nCPAP of claim 15 , wherein said flow enhancer is spaced a distance apart from an interior surface of said generator body to accommodate said second pathway.

19. The nCPAP of claim 18 , wherein said flow enhancer circles around said interior surface of said generator body.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Dec 13, 2024
From: VYAIRE MEDICAL, INC., ET AL.'S CREDITORS
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069635/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2024
From: VYAIRE MEDICAL CAPITAL LLC
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069455/0906 →
SECURITY INTEREST Recorded May 9, 2019
From: VYAIRE MEDICAL CAPITAL LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049130/0206 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VYAIRE MEDICAL CAPITAL LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0895 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VYAIRE MEDICAL CAPITAL LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045969/0642 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2018
From: CITIZENS BANK, N.A.
To: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; CAREFUSION 202, INC.; VITAL SIGNS, INC.
Reel/Frame 045779/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY 102 LLC
To: KINGSTON RESPIRATORY CAPITAL LLC
Reel/Frame 040372/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: CAREFUSION 303, INC.
To: CAREFUSION 2200, INC.
Reel/Frame 040372/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: CAREFUSION 2200, INC.
To: KINGSTON RESPIRATORY 102 LLC
Reel/Frame 040372/0903 →
CHANGE OF NAME Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY CAPITAL LLC
To: VYAIRE MEDICAL CAPITAL LLC
Reel/Frame 040652/0311 →
SECURITY AGREEMENT Recorded Oct 14, 2016
From: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; VITAL SIGNS, INC.; CAREFUSION 202, INC.
To: CITIZENS BANK, N.A, AS COLLATERAL AGENT
Reel/Frame 040357/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2011
From: MANSOUR, KHALID
To: CAREFUSION 303, INC.
Reel/Frame 025767/0651 →